Table of Content

1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients Manufacturing
1.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value Comparison by Type (2024-2034)
1.2.2 Antiparasitic
1.2.3 Anti-infectives
1.2.4 NSAIDs
1.2.5 Others
1.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value by Application: (2024-2034)
1.3.2 Companion Animals
1.3.3 Production/Food Animals
1.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Estimates and Forecasts
1.4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue 2024-2034
1.4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales 2024-2034
1.4.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competition by Manufacturers
2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Manufacturers (2024-2024)
2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Price by Manufacturers (2024-2024)
2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Product Type & Application
2.7 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Situation and Trends
2.7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Active Pharmaceutical Ingredients Manufacturing Players Market Share by Revenue
2.7.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Active Pharmaceutical Ingredients Manufacturing Retrospective Market Scenario by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2024-2034
3.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2024-2024
3.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2024-2034
3.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2024-2034
3.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2024-2024
3.3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2024-2034
3.4 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Facts & Figures by Country
3.4.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034)
3.4.3 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Facts & Figures by Country
3.5.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034)
3.5.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034)
3.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Facts & Figures by Country
3.7.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034)
3.7.3 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034)
3.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2034)
4.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2034)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Type (2024-2034)
4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2024-2034)
4.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2024-2024)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2024-2034)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Type (2024-2034)
4.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Type (2024-2034)
5 Segment by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2034)
5.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024)
5.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2034)
5.1.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Application (2024-2034)
5.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2024-2034)
5.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2024-2024)
5.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2024-2034)
5.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Application (2024-2034)
5.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Alivira Animal Health Ltd.
6.1.1 Alivira Animal Health Ltd. Corporation Information
6.1.2 Alivira Animal Health Ltd. Description and Business Overview
6.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.1.5 Alivira Animal Health Ltd. Recent Developments/Updates
6.2 Excel Industries Ltd.
6.2.1 Excel Industries Ltd. Corporation Information
6.2.2 Excel Industries Ltd. Description and Business Overview
6.2.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.2.5 Excel Industries Ltd. Recent Developments/Updates
6.3 Ofichem Group
6.3.1 Ofichem Group Corporation Information
6.3.2 Ofichem Group Description and Business Overview
6.3.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.3.5 Ofichem Group Recent Developments/Updates
6.4 Chempro Pharma Private Ltd.
6.4.1 Chempro Pharma Private Ltd. Corporation Information
6.4.2 Chempro Pharma Private Ltd. Description and Business Overview
6.4.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.4.5 Chempro Pharma Private Ltd. Recent Developments/Updates
6.5 Menadiona
6.5.1 Menadiona Corporation Information
6.5.2 Menadiona Description and Business Overview
6.5.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.5.5 Menadiona Recent Developments/Updates
6.6 SUANFARMA
6.6.1 SUANFARMA Corporation Information
6.6.2 SUANFARMA Description and Business Overview
6.6.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.6.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.6.5 SUANFARMA Recent Developments/Updates
6.7 Vetpharma (Insud Pharma, S.L.U)
6.6.1 Vetpharma (Insud Pharma, S.L.U) Corporation Information
6.6.2 Vetpharma (Insud Pharma, S.L.U) Description and Business Overview
6.6.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.7.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments/Updates
6.8 Siflon Drugs
6.8.1 Siflon Drugs Corporation Information
6.8.2 Siflon Drugs Description and Business Overview
6.8.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.8.5 Siflon Drugs Recent Developments/Updates
6.9 Qilu Pharma
6.9.1 Qilu Pharma Corporation Information
6.9.2 Qilu Pharma Description and Business Overview
6.9.3 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.9.5 Qilu Pharma Recent Developments/Updates
6.10 FIS - Fabbrica Italiana Sintetici S.p.A.
6.10.1 FIS - Fabbrica Italiana Sintetici S.p.A. Corporation Information
6.10.2 FIS - Fabbrica Italiana Sintetici S.p.A. Description and Business Overview
6.10.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
6.10.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.10.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain Analysis
7.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Production Mode & Process
7.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales and Marketing
7.4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Channels
7.4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Distributors
7.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Customers
8 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
8.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
8.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
8.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges
8.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) of Key Manufacturers (2024-2024)
Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Veterinary Active Pharmaceutical Ingredients Manufacturing Average Price (US$/Ton) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (Tons)
Table 18. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Region (2024-2024)
Table 19. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (Tons)
Table 20. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Region (2024-2034)
Table 21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Region (2024-2024)
Table 23. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Region (2024-2034)
Table 25. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 27. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 28. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 32. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 33. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (Tons)
Table 37. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (Tons)
Table 38. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 42. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 43. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 47. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 48. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2024)
Table 51. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2034)
Table 52. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Type (2024-2024)
Table 53. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Type (2024-2034)
Table 54. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Type (2024-2024)
Table 57. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Type (2024-2034)
Table 58. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Type (2024-2024)
Table 59. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Type (2024-2034)
Table 60. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Application (2024-2024)
Table 61. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Application (2024-2034)
Table 62. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Application (2024-2024)
Table 63. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Application (2024-2034)
Table 64. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Application (2024-2024)
Table 67. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Application (2024-2034)
Table 68. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Application (2024-2024)
Table 69. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Application (2024-2034)
Table 70. Alivira Animal Health Ltd. Corporation Information
Table 71. Alivira Animal Health Ltd. Description and Business Overview
Table 72. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 73. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 74. Alivira Animal Health Ltd. Recent Developments/Updates
Table 75. Excel Industries Ltd. Corporation Information
Table 76. Excel Industries Ltd. Description and Business Overview
Table 77. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 78. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 79. Excel Industries Ltd. Recent Developments/Updates
Table 80. Ofichem Group Corporation Information
Table 81. Ofichem Group Description and Business Overview
Table 82. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 83. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 84. Ofichem Group Recent Developments/Updates
Table 85. Chempro Pharma Private Ltd. Corporation Information
Table 86. Chempro Pharma Private Ltd. Description and Business Overview
Table 87. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 88. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 89. Chempro Pharma Private Ltd. Recent Developments/Updates
Table 90. Menadiona Corporation Information
Table 91. Menadiona Description and Business Overview
Table 92. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 93. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 94. Menadiona Recent Developments/Updates
Table 95. SUANFARMA Corporation Information
Table 96. SUANFARMA Description and Business Overview
Table 97. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 98. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 99. SUANFARMA Recent Developments/Updates
Table 100. Vetpharma (Insud Pharma, S.L.U) Corporation Information
Table 101. Vetpharma (Insud Pharma, S.L.U) Description and Business Overview
Table 102. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 103. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 104. Vetpharma (Insud Pharma, S.L.U) Recent Developments/Updates
Table 105. Siflon Drugs Corporation Information
Table 106. Siflon Drugs Description and Business Overview
Table 107. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 108. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 109. Siflon Drugs Recent Developments/Updates
Table 110. Qilu Pharma Corporation Information
Table 111. Qilu Pharma Description and Business Overview
Table 112. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 113. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 114. Qilu Pharma Recent Developments/Updates
Table 115. FIS - Fabbrica Italiana Sintetici S.p.A. Corporation Information
Table 116. FIS - Fabbrica Italiana Sintetici S.p.A. Description and Business Overview
Table 117. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 118. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 119. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Veterinary Active Pharmaceutical Ingredients Manufacturing Distributors List
Table 123. Veterinary Active Pharmaceutical Ingredients Manufacturing Customers List
Table 124. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
Table 125. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
Table 126. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges
Table 127. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Active Pharmaceutical Ingredients Manufacturing
Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Type in 2022 & 2034
Figure 4. Antiparasitic Product Picture
Figure 5. Anti-infectives Product Picture
Figure 6. NSAIDs Product Picture
Figure 7. Others Product Picture
Figure 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Application in 2022 & 2034
Figure 10. Companion Animals
Figure 11. Production/Food Animals
Figure 12. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2024-2034) & (US$ Million)
Figure 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (2024-2034) & (Tons)
Figure 15. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Price (US$/Ton) & (2024-2034)
Figure 16. Veterinary Active Pharmaceutical Ingredients Manufacturing Report Years Considered
Figure 17. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Share by Manufacturers in 2022
Figure 18. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Veterinary Active Pharmaceutical Ingredients Manufacturing Players: Market Share by Revenue in 2022
Figure 20. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country (2024-2034)
Figure 23. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Country (2024-2034)
Figure 24. United States Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country (2024-2034)
Figure 27. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Country (2024-2034)
Figure 28. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Region (2024-2034)
Figure 35. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country (2024-2034)
Figure 43. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients Manufacturing by Type (2024-2034)
Figure 53. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients Manufacturing by Type (2024-2034)
Figure 54. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Type (2024-2034)
Figure 55. Global Sales Market Share of Veterinary Active Pharmaceutical Ingredients Manufacturing by Application (2024-2034)
Figure 56. Global Revenue Market Share of Veterinary Active Pharmaceutical Ingredients Manufacturing by Application (2024-2034)
Figure 57. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price (US$/Ton) by Application (2024-2034)
Figure 58. Veterinary Active Pharmaceutical Ingredients Manufacturing Value Chain
Figure 59. Veterinary Active Pharmaceutical Ingredients Manufacturing Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed